Mankind Pharma earns 'B' ESG rating from MSCI

Mankind Pharma Limited disclosed today that MSCI ESG Ratings and Research Private Limited ("MSCI") has assigned an ESG rating of 'B' to the company. This intimation was made pursuant to Regulations 30 and 51 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company received the ESG Report on November 4, 2025. MSCI issued this report independently, and Mankind Pharma Limited did not engage MSCI for the rating process. Further details regarding this disclosure are available on the company's official website.

This rating provides key insight into Mankind Pharma's performance on various environmental, social, and governance factors, offering valuable information to stakeholders and the market.